Chitra Fernando, MD March 18, 2008

Similar documents
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Katee Kindler, PharmD, BCACP

Geriatric Pharmacology

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition


STOPP and START criteria October 2011

Psychotropic Medication Use in Dementia

BEERs For the Elderly

Prescribing Drugs to the Elderly

Management of Delirium in Hospice Patients

University of Hawaii Center on Aging

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

Antipsychotic Use in the Elderly

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Definition and Statistics

Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia

STOPP START Toolkit Supporting Medication Review in the Older Person

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

Pharmacology in the Elderly

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017

SEDATIVE-HYPNOTIC AGENTS

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Instruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy

Use of Psychotropic Medications in Older Adults with Dementia!

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care

How to Teach About Drugs and Aging

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Antipsychotic Medications

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS

Residents Who Don t Sleep

Reduction of High Risk Medications Using A Quality Initiative Perspective

BACKGROUND Measuring renal function :

PSYCHOTROPIC SOLUTIONS

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

Nortriptyline vs amitriptyline in elderly

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug:

Safe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science

Tricyclic Antidespressants: Actions

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.)

Pharmaceutical Care for Geriatrics

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Aging Changes That Impact Medication Management

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Medication Use in Older Adults

Psycholeptics, anti-depressants, antiepileptic, anti-ra and anti-spastic medications available at Zithulele hospital

Cetirizine Proposed Core Safety Profile

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Prescribing and Pharmacokinetic Considerations in the Elderly

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Anthony J. Caprio, MD, CMD, AGSF 1

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Preventing Falls in Older Adults A Matter of Safety

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

3. Atypical antidepressants

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Presentation Outline. Meet Gloria, Robert and Alfred So, you live in Wisconsin?! Fall Risk Equation Treatment/Prevention what works and what doesn t!

Antidepressant Pharmacology An Overview

Chapter 161 Antipsychotics

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Drugs for Emotional and Mood Disorders Chapter 16

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

Delirium. Assessment and Management

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources

Polypharmacy 101. Acknowledgements. Disclosure. with special thanks to Jen Lehman, PharmD candidate

PRODUCT INFORMATION. Ammonium chloride is an expectorant that has an irritant effect on mucous membranes.

DEPRESCRIBING IN THE ELDERLY

Pitfalls in Pharmacotherapy of Geriatrics

Depression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012

Public Dissemination Effective: January 2018

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

120 mg/day. 120 mg/day. 120 mg/day. 60 mg/day. 60 mg/day. 60 mg/day

Management of Behavioral Problems in Dementia

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 &

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS:

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Common Antidepressant Medications for Adults

disease or in clients who consume alcohol on a regular basis. bilirubin

Medication Prescribing for Older Adults

Transcription:

Chitra Fernando, MD March 18, 2008

Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse drug reactions

ADE is an Injury resulting from use of a drug Medication side effects Allergic reactions Medication interactions

ADE - responsible for 5-28% acute geriatric medical admissions. 80% of ADE are due to prescription medications The risk of an adverse reaction increases with every new drug added to the treatment regimen. 140,000 deaths per year due to ADE 95% ADE are predictable and 50% preventable

Age > 85 y Low body wt/bmi > 6 concurrent chronic diagnosis Cr clearance < 50 ml/min > 9 meds > 12 doses/day Prior adverse drug reaction Several prescribing Physicians > 1 Pharmacy

More medical problems More medications/drug interactions Pharmacoeconomic issues Age associated changes in pharmacokinetics and pharmacodynamics

Decreased lean body mass and body water content - Increased concentration of water soluble medications. Eg: Li, Digoxin Increased body fat content fat soluble medications takes longer to clear. Eg: Diazepam, Trazedon Decreased serum albumin increased unbound fraction of med-eg: Phenytoin, Valproic acid, Cefriaxone, Warfarin

Decreased metabolism (decreased liver mass & blood supply) Decreased clearance (decreased no of functioning nephrons and decreased renal blood flow ) Increased sensitivity. Eg: Narcotics, Benzo, Psychotropic, Anticholinergics

Increased falls Confusion Sedation Decreased oral intake Constipation/urinary retention Failure to thrive It is not uncommon for a physician to treat an ADE with another medication.

Inappropriate greater potential to harm than to benefit Beers criteria introduced in 1991 by Beers et al Original criteria was written for elderly persons who were institutionalized and updated in 1997 and 2003 to include all persons over age 65.

Defined medications that should not be prescribed to elderly patients & other medications for which doses, frequencies, durations should not be exceeded.

Beers criteria is widely used as a measure of health care quality and safety Center for Medicare & Medicaid services incorporated Beers criteria into Federal safety regulations for long term care facilities in 1999.

41 medications - Inappropriate under any circumstances 7 medications Inappropriate when used over certain doses, frequencies and durations

Dry mouth, increased thirst, urinary retention, constipation Hypotension, Tachycardia, cardiac arrhythmias, heart blocks

Post op delirium, agitation, hallucination, cognitive impairment, increased risk of falls Pupillary dilatation worsening closed angle glaucoma may threaten vision

TCA Antihistamines-Diphenhydramine (Benadryl) Hydroxyzine (vistaril, Atarax) Antipharkinsonian drugs with atrophine like activity. Oxybutynin, Tolterodine Hyoscyamine Phenothiazine Anticholinergic toxicity occurs more often when two or more anticholinergic drugs are taken together.

High lipid solubility- slower elimination Binds exclusively to plasma proteins-higher plasma drug levels Risk of 2 0,3 0 heart block - pre existing heart disease. Anticholinergic SE - Orthostatic hypotension, falls and fractures

Tertiary amines-amitriptyline, impramine- more anti cho.se Secondary- nortriptyline and desipramine less anti cho. SE Low dose- neuropathic pain SSRI is a better alternative for depression

To manage behaviors associated with dementia-paranoia, agitation, hallucinations & delusions Not usefull in wandering, pacing, repetitive vocalizations

Anticholinergic effects, EP symptoms (bradykinesia, stiffness, cogwheel rigidity, akinesia, akathisia) Lasts longer after d/c. It is not uncommon to treat EP side effects with anticholinergic antiparkinsonian meds results in excessive anticholinergic activity

Atypical antiphychotic medications improved safety profile Clozapine agranulocytosis Olanzapine, Risperidone, Quetiapine Fever extrapyramidal effects and TD

Older-Diazepam, chlordiazepoxide, flurazepam highly lipid soluble Newer-Lorazepam, oxazepam low lipid soluble in low doses only for short term use when indicated

Older (diphenhydramine)- cross BBB Hypnotic, cognitive slowing, delirium, falls more if pre-existing cognitive impairment Second generation antihistamines Fexofenadine, loratadine, cetrizine safer, no notable central effects

10 20% of > 65 yr 15-35% of all peptic ulcer disease due to NSAIDs 20,000 patients die each year

Many present with serious upper GI bleeding 60% individuals with mucosal erosions from NSAIDs were asymptomatic Naproxen, Piroxicam Other SE include Renal impairement, hyperkalemia, HTN, fluid retention, CHF, Indomethacin CNS toxicity Alternatives Acetaminophen, tramadol

2004-2005 ADE requiring ER visits (177504) 3.6% - From Beers criteria 17.3% - Warferin 13% - Insulin 3.2% - Digoxin

ACEI,Potassium sparing diuretics, potassium Benzo, antidepresent, antipsycotic Digoxin, Antiarrhythmics, verapamil Warfarin, NSAIDs, sulfa drugs, macrolides, quinolones, phenyton

When starting meds for chronic medical conditions, start low and go slow Try not to start two medications at the same time

New complaints, worsening of an existing condition R/O SE of medications Discontinue any medication no longer indicated Consider non-pharmacological interventions Avoid drug Interactions - Duplicating side effects

Consider medications with more than one therapeutic effects Brown bag evaluation Maintain accurate records

Educate patient and the care giver about the new medications Simplify the profile Use only one pharmacy Consult pharmacists

Saw palmetto Common use? BPH Adverse Events? Headache, nausea, GI distress, ED

St. John s wort Common uses? Depression, anxiety Adverse Events? Photosensitivity, hypomania

Ginkgo Common uses? Alzheimer s disease, memory, intermittent claudication, macular degeneration Adverse Events? Bleeding, headache, nausea, GI upset, diarrhea, anxiety

Ginseng Common use? Physical & mental performance enhancer Adverse Events? Hypertension, tachycardia

Garlic Common uses? Hypertension, hypercholesterolemia, platelet inhibitor Adverse Events? Bleeding, GI upset, hypoglycemia

Ginger Common uses? Antiemetic, anti-inflammatory, dyspepsia Adverse Events? Bleeding

Kava kava Common uses? Anxiety, sedative Adverse Events? Sedation, hepatotoxicity

Echinacea Common use? Immune stimulant Adverse Events? Hepatotoxicity

Feverfew Common uses? Anti-inflammatory, migraine prophylaxis Adverse Events? Platelet inhibition, bleeding, GI upset

Glucosamine Common uses? Osteoarthritis, rheumatoid arthritis Adverse Events? GI distress, anorexia, insomnia, painful & itchy skin, peripheral edema, tachycardia